Next-generation of mesothelin-targeted CAR-T cells secreting anti-PD-L1 scFv for potent immunotherapy against 3D patient-derived colorectal cancer organoids

This diagnostic/model validation study was triaged for T6 - Novel Therapeutics (immunotherapy/CAR-T) based on abstract review. It appears high priority because it addresses a direct clinical or diagnostic question with moderate evidence maturity.

This diagnostic/model validation study was triaged for T6 - Novel Therapeutics (immunotherapy/CAR-T) based on abstract review. It appears high priority because it addresses a direct clinical or diagnostic question with moderate evidence maturity.

What the study was

Study design

Diagnostic/model validation study

Maturity

Validated

Journal

BMC medicine

A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.